Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Biomed Res Int ; 2021: 3502325, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34423033

RESUMO

Obesity, as the most common metabolic disorder in the world, is characterized by excess body fat. This study is aimed at determining the effects of melatonin supplementation on body weight, nody mass index (BMI), waist circumference (WC), and body fat mass percentage (BFMP) in people with overweight or obesity. Thirty eight overweight or class-I obese adult individuals were recruited in the study (8 men and 30 women). Participants prescribed a weight-loss diet and then randomly were allocated to melatonin or placebo groups. Participants received either a 3-milligram melatonin or placebo tablet per day for 12 weeks. In order to assess differences at the significance level of 0.05, repeated measure ANOVA and paired t-test were used. According to the results, a significant reduction was found in participants' body weight, WC, and BMI in both groups (p = 0.001). However, for the last six weeks, significant reductions of these parameters were observed only in the melatonin group (p = 0.01). The BFMP of participants in the melatonin group showed a significant reduction at the end of the study compared to the initial measurements (p = 0.008). Nevertheless, the results of the present study alone are not sufficient to conclude on the effects of melatonin consumption on anthropometric indices, and it seems that further studies are required in this regard.


Assuntos
Peso Corporal/efeitos dos fármacos , Melatonina/administração & dosagem , Obesidade/dietoterapia , Sobrepeso/dietoterapia , Circunferência da Cintura/efeitos dos fármacos , Adulto , Antropometria , Composição Corporal/efeitos dos fármacos , Índice de Massa Corporal , Dieta Redutora , Método Duplo-Cego , Feminino , Humanos , Irã (Geográfico) , Masculino , Melatonina/farmacologia , Pessoa de Meia-Idade , Resultado do Tratamento
2.
Burns ; 41(3): 493-6, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25306088

RESUMO

The purpose of this study was to evaluate the effect of consumption of oral olive oil on clinical outcomes and wound healing of thermally injured patients with hospital stays. One hundred patients (mean age; 33.34±7 years) with 10-20% total body surface area, deep second degree and more burn wounds were randomized to receive either oral olive oil or sunflower oil as the oil in their diet. Patients were evaluated daily for occurrence of wound infection, sepsis and healing of the grafted skin. Also the duration of hospitalization and admission to the intensive care unit were compared in two groups. Results showed that there was no significant difference between the olive oil group and the control group in percent of TBSA involvement (14.28±0.53 vs. 13.02±0.48, P=0.7), albumin concentration (3.25±0.5 vs. 3.13±0.5, P=0.5) and mean calorie intake (2034±216.9 kcal vs2118±192.1 kcal, P=0.2). We found a significant difference in the duration of wound healing (7.2±0.5 vs. 8.7±0.5, P=0.04) and duration of hospitalization (7.4±0.5 vs. 8.9±0.4, P=0.05) in the olive oil group versus the control group. We did not find any difference in ICU admission, wound infection and occurrence of sepsis between two groups. This study showed that an oral diet provided with olive oil in patients with burn may accelerate wound healing and decrease the duration of hospitalization.


Assuntos
Queimaduras/dietoterapia , Azeite de Oliva/uso terapêutico , Cicatrização , Adolescente , Adulto , Superfície Corporal , Feminino , Hospitalização , Humanos , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Óleos de Plantas/uso terapêutico , Óleo de Girassol , Resultado do Tratamento , Adulto Jovem
3.
Diabetes Res Clin Pract ; 93(1): 86-94, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21496936

RESUMO

AIM: The aim of the present study was to determine if micronutrients supplementation can improve neuropathy indices in type 2 diabetes. MATERIALS AND METHODS: In this randomized, double-blind, placebo-controlled clinical trial, 75 type 2 diabetes patients were assigned to three treatment groups, receiving one of the following daily supplement for 4 months: Group MV: zinc (20 mg), magnesium (250 mg), vitamin C (200 mg) and E (100 mg); Group MVB: both of the above mineral and vitamin supplements plus vitamin B1 (10 mg), B2 (10 mg), B6 (10 mg), biotin (200 µg), B12 (10 µg) and folic acid (1 mg); Group P: placebo. RESULTS: 67 patients completed the study. Neuropathic symptoms based on the MNSI questionnaire improved from 3.45 to 0.64 (p=0.001) in group MVB, from 3.96 to 1.0 (p=0.001) in group MV and from 2.54 to 1.95 in placebo group after 4 months. There was no significant difference between three treatment groups in MNSI examinations after 4 months supplementations. Over 4 months of treatment, patients showed no significant changes in glycemic control, capillary blood flow or electrophysiological measures in MV and MVB groups compared with placebo group. CONCLUSIONS: These studies suggest that micronutrients supplementation might ameliorate diabetic neuropathy symptoms.


Assuntos
Diabetes Mellitus Tipo 2/dietoterapia , Neuropatias Diabéticas/dietoterapia , Micronutrientes/uso terapêutico , Adulto , Idoso , Suplementos Nutricionais , Método Duplo-Cego , Feminino , Humanos , Óxido de Magnésio/uso terapêutico , Masculino , Pessoa de Meia-Idade , Vitaminas/uso terapêutico , Sulfato de Zinco/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA